KORU Medical Systems (KRMD) Cash from Operations (2010 - 2026)
KORU Medical Systems' (KRMD) quarterly Cash from Operations came in at $216113.0 in Q2 2026, up 146.95% year-over-year from $87514.1 in Q2 2025, and up 1373.87% quarter-over-quarter from $14663.0 in Q1 2026.
Analysis
KORU Medical Systems (KRMD) Cash from Operations (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported Cash from Operations for 12 consecutive years, with $216113.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 146.95% year-over-year to $216113.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a 303.92% increase from a year earlier, with the FY2025 full-year figure at $462405.0, up 244.63% from the prior year.
- Cash from Operations was $216113.0 for Q2 2026 at KORU Medical Systems, up from $14663.0 in the prior quarter.
- Over five years, Cash from Operations peaked at $1.3 million in Q4 2022 and troughed at -$4.7 million in Q1 2023.
- A 5-year average of -$551313.3 and a median of -$195702.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations soared 286.36% in 2022 and sank 4161.23% in 2025, its largest moves.
- Over 5 years, Cash from Operations stood at $1.3 million in 2022, then retreated by 17.93% to $1.1 million in 2023, then slipped by 14.33% to $939615.0 in 2024, then advanced by 16.51% to $1.1 million in 2025, then tumbled by 80.26% to $216113.0 in 2026.
- The last three Cash from Operations figures came in at $216113.0 (Q2 2026), $14663.0 (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 367.10 Mn |
| 10 | KORU Medical Systems | 144.70 Mn | 136.40 Mn | 7.85 Mn | 216,113.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 216,113.00 |
| Mar 31, 2026 | 14,663.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 65,456.00 |
| Jun 30, 2025 | -460,340.00 |
| Mar 31, 2025 | -237,467.00 |
| Dec 31, 2024 | 939,615.00 |
| Sep 30, 2024 | -923,948.00 |
| Jun 30, 2024 | 11,335.00 |
| Mar 31, 2024 | -346,720.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -153,937.00 |
| Mar 31, 2023 | -4.66 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | -2.12 Mn |
| Jun 30, 2022 | -2.87 Mn |
| Mar 31, 2022 | -1.75 Mn |
| Dec 31, 2021 | -717,132.00 |
| Sep 30, 2021 | -826,228.00 |